An Endogenous Cannabinoid as an Endothelium-Derived Vasorelaxant

Authors: Randall M.D.1; Alexander S.P.H.1; Bennett T.1; Boyd E.A.2; Fry J.R.1; Gardiner S.M.1; Kemp P.A.1; Mcculloch A.I.1; Kendall D.A.1

Source: Biochemical and Biophysical Research Communications, Volume 229, Number 1, December 1996 , pp. 114-120(7)

Publisher: Academic Press

Buy & download fulltext article:

OR

Price: $52.63 plus tax (Refund Policy)

Abstract:

Since the identification of nitric oxide (NO) as an important mediator of endothelium-dependent relaxation, it has become clear that there is an additional endothelial relaxant factor, termed the endothelium-derived hyperpolarizing factor (EDHF). The identity of EDHF has remained elusive, but it is thought to be an arachidonic acid metabolite. We now report that EDHF-mediated relaxations in the rat mesenteric arterial bed are blocked by a highly selective cannabinoid receptor antagonist, SR141716A, consistent with EDHF being a cannabinoid-like substance. Furthermore, in conscious rats, the NO-independent depressor and regional vasodilator effects of bradykinin were inhibited by SR141716A. The relaxations in the isolated mesentery were accompanied by the accumulation of an arachidonic acid metabolite, which co-eluted on TLC separation with arachidonoylethanolamide (anandamide), an endogenous cannabinoid derived from arachidonate. We further report that anandamide is a potent vasorelaxant in the mesentery, acting via a hyperpolarizing mechanism. These findings suggest that an endogenous cannabinoid is an endothelium-derived vasorelaxant, which may be EDHF.

Language: English

Document Type: Research article

Affiliations: 1: Department of Physiology and Pharmacology, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, United Kingdom 2: Department of Pharmaceutical Sciences, University of Nottingham, Nottingham, NG7 2RD, United Kingdom

Publication date: 1996-12-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page